Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
Insider tradingForm 4

Quoin Pharmaceuticals Ltd. (QNRX) Insider Trading

4 open-market trades reported since Sep 1, 2026: 4 purchases worth $280K and 0 sales worth $0.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Michael MyersCEO1$100K0$0Sep 1, 2026
Denise P. CarterCOO1$100K0$0Sep 1, 2026
Sally Bridget LawlorCFO1$50K0$0Sep 1, 2026
Anthony James CulverwellDirector1$30K0$0Sep 1, 2026
ADVERTISEMENT
728 × 90 ad slot320 × 100 ad slot

All trades

QNRX insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Sep 1Aug 31Michael MyersCEOCEO▲ BUY20,4904.88$100K+119%Form 4 ↗
Sep 1Aug 31Denise P. CarterCOOCOO▲ BUY20,4904.88$100K+119%Form 4 ↗
Sep 1Aug 31Sally Bridget LawlorCFOCFO▲ BUY10,2444.88$50K+2.3K%Form 4 ↗
Sep 1Aug 31Anthony James CulverwellDirectorDirector▲ BUY6,1464.88$30K+18%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings